Showing 5341-5350 of 5956 results for "".
- Clearwave Launches New Patient Interface Solutionhttps://modernod.com/news/clearwave-launches-new-patient-interface-solution/2477249/Clearwave, a provider of patient check-in solutions via mobile, kiosk, and desktop, announced the launch of Clearwave Connect, a new tablet-based application to enhance front-office experiences. With Clearwave Connect, practices will have the ability to improve check-in speed and accessibility wi
- Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma’s Impact on Daily Livinghttps://modernod.com/news/allergan-teams-up-with-super-bowl-mvp-von-miller-to-raise-awareness-of-glaucomas-impact-on-daily-living/2477236/Allergan announced a partnership with Von Miller, Super Bowl MVP, Denver Broncos linebacker, and advocate for healthy vision, to shine a light on the millions of people living with glaucoma. As an ambassador for the ‘My Glaucoma’ campaign, Mr. Miller wil
- Bionic Vision Technologies Announces Interim Pilot Study Results of the BVT Bionic Eye Systemhttps://modernod.com/news/bionic-vision-technologies-announces-interim-pilot-study-results-of-the-bvt-bionic-eye-system/2477228/Bionic Vision Technologies announced interim results of a pilot study involving 4 patients with late-stage retinitis pigmentosa (RP) implanted with a visual prosthesis designed to improve awareness of external objects
- Aura Biosciences Appoints George Golumbeski, PhD, as Chairman of the Board of Directorshttps://modernod.com/news/aura-biosciences-appoints-george-golumbeski-phd-as-chairman-of-the-board-of-directors/2477212/Aura Biosciences announced the appointment of George Golumbeski, PhD, as Chairman of its Board of Directors. Dr. Golumbeski is a biopharmaceutical business leader with over 25 years of experience in the biotechnology industry. “George’s extensive experience will be invaluable to Aura as we
- The Firmament Group Invests in Three Ophthalmology Practices and an ASC in St. Louishttps://modernod.com/news/the-firmament-group-invests-in-three-ophthalmology-practices-and-an-asc-in-st-louis/2477206/The Firmament Group announced an investment in three ophthalmology practices and an ambulatory surgery center in St. Louis. Terms of the deal were not disclosed. Firmament previously invested in practices in Southern Florida
- IrisVision and Samsung Announce Partnership to Bring Clinically Validated Vision Technologies to Over 200 Million Low Vision Patients Globallyhttps://modernod.com/news/irisvision-and-samsung-announce-partnership-to-bring-clinically-validated-vision-technologies-to-over-200-million-low-vision-patients-globally/2477207/Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform uses the power of Samsung’s Galaxy smartphones, XR devices, and mobile AI platform to enable people
- Laundry Pods Cause Growing Number of Eye Injuries in U.S.https://modernod.com/news/laundry-pods-cause-growing-number-of-eye-injuries-in-u-s/2477198/A growing number of kids are getting chemicals from laundry detergent pods in their eyes, even as ocular injuries from other types of household cleaners steadily decline, a U.S. study suggests, Reuters reported. Nationwide, poison c
- 10 Best Foods to Protect Your Eyesighthttps://modernod.com/news/10-best-foods-to-protect-your-eyesight/2477196/As we approach the new year and new decade, many of us are focused on a new vision for our lives. But in order to protect the vision we have, experts say that eating certain foods can help us preserve our eyesight and prevent ocular diseases. “Antioxidants have been long known to hel
- CooperVision Launches First Best Practices Scholarship Programhttps://modernod.com/news/coopervision-launches-first-best-practices-scholarship-program/2477193/To enable future eye care professionals to learn from some of the best in optometry, CooperVision announced the launch of its first “Best Practices Scholarship Program.” The scholarship—offered to third-year optometry students—is an expansion of the company’s annual Best Practices ini
- Lineage Provides Update on Patient Enrollment in Phase 1/2a Clinical Study of OpRegen for the Treatment of Dry AMDhttps://modernod.com/news/lineage-provides-update-on-patient-enrollment-in-phase-1-2a-clinical-study-of-opregen-for-the-treatment-of-dry-amd/2477194/Lineage Cell Therapeutics announced additional patient data from its ongoing phase 1/2a clinical study of OpRegen, the company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry age-related macular degeneration (AMD). The first Cohort 4 patient treated using bo